For assistance, please contact a Patient Case Coordinator by dialing 1-855-727-6274

For assistance,
call 1-855-727-6274

Home

Making
a real
difference
in people's
lives

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides eligible patients
with prescribed Otsuka medication free of cost.

The Otsuka Patient Assistance
Foundation, Inc. (OPAF) is a
nonprofit organization that provides
eligible patients with prescribed Otsuka
medication free of cost.

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides eligible patients
with prescribed Otsuka medication free of cost.

The Otsuka Patient Assistance Foundation, Inc. (OPAF)
is a nonprofit organization that provides eligible patients
with prescribed Otsuka medication free of cost.

Patients Who Are Prescribed JYNARQUE® (tolvaptan)
May Be Eligible for Assistance!

OPAF is extending no-cost coverage to eligible patients who are being treated with:

Jynarque (tolvaptan) tablets

 

Please see U.S. FULL PRESCRIBING INFORMATION,
including BOXED WARNING and MEDICATION GUIDE.

Please see U.S. FULL PRESCRIBING
INFORMATION, including BOXED
WARNING and MEDICATION GUIDE.

 

Check for No-Cost
Assistance Check for No-Cost Assistance

Eligible patients can receive
no-cost assistance for certain Otsuka
medications through OPAF.

Eligible patients can receive no-cost assistance for certain
Otsuka medications through OPAF.

 
Website_Arrow

OPAF Care Connect

Are you a U.S. healthcare
professional? Access the
OPAF Care Connect Portal to:

Are you a U.S. healthcare professional?
Access the OPAF Care Connect Portal to:

  • Submit OPAF applications online
  • Send product orders
  • Access patient documentation
  • Track order shipping
  • Submit OPAF applications online
  • Send product orders
  • Access patient documentation
  • Track order shipping

Supported Medications

OPAF provides the following prescribed medications free of cost for eligible patients:

OPAF provides the following
prescribed medications free of cost
for eligible patients:

ABILIFY MAINTENA® (aripiprazole) for extended injectable suspension
JYNARQUE™ (tolvaptan) tablets
REXULTI® (brexpiprazole) tablets
SAMSCA® (tolvaptan) tablets

See U.S. FULL PRESCRIBING INFORMATION,
including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE,
REXULTI, and SAMSCA.

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

See MEDICATION GUIDES for
ABILIFY MAINTENA, JYNARQUE,
REXULTI, and SAMSCA.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS,
contact Otsuka America Pharmaceutical, Inc.
at 1-800-438-9927 or FDA at 1-800-FDA-1088
(www.fda.gov/medwatch).

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation distributes funds.

Are you sure you want to leave Otsuka Patient Assistance Foundation?

Healthcare professionals apply to Otsuka Patient Assistance Foundation (OPAF) on a patient’s behalf.

If you are a healthcare professional, continue to OPAF Care Connect to apply. If you are a patient, speak to your healthcare provider about applying for OPAF.